Global Radioligand Therapy Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Radioligand Therapy Market Size 2017-2028

2.1.2 Radioligand Therapy Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Radioligand Therapy Segment by Used Radionuclides

2.2.1 Actinium 225 (Ac-225)

2.2.2 Lutetium 177 (Lu-177)

2.2.3 Gallium 68 (Ga-68)

2.2.4 Fluorine 18 (F-18)

2.2.5 Other Radionuclides

2.3 Radioligand Therapy Market Size by Used Radionuclides

2.3.1 Radioligand Therapy Market Size CAGR by Used Radionuclides (2017 VS 2022 VS 2028)

2.3.2 Global Radioligand Therapy Market Size Market Share by Used Radionuclides (2017-2022)

2.4 Radioligand Therapy Segment by Application

2.4.1 Neuroendocrine Neoplasms

2.4.2 Prostate Cancer

2.5 Radioligand Therapy Market Size by Application

2.5.1 Radioligand Therapy Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Radioligand Therapy Market Size Market Share by Application (2017-2022)

3 Radioligand Therapy Market Size by Player

3.1 Radioligand Therapy Market Size Market Share by Players

3.1.1 Global Radioligand Therapy Revenue by Players (2020-2022)

3.1.2 Global Radioligand Therapy Revenue Market Share by Players (2020-2022)

3.2 Global Radioligand Therapy Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Radioligand Therapy by Regions

4.1 Radioligand Therapy Market Size by Regions (2017-2022)

4.2 Americas Radioligand Therapy Market Size Growth (2017-2022)

4.3 APAC Radioligand Therapy Market Size Growth (2017-2022)

4.4 Europe Radioligand Therapy Market Size Growth (2017-2022)

4.5 Middle East & Africa Radioligand Therapy Market Size Growth (2017-2022)

5 Americas

5.1 Americas Radioligand Therapy Market Size by Country (2017-2022)

5.2 Americas Radioligand Therapy Market Size by Used Radionuclides (2017-2022)

5.3 Americas Radioligand Therapy Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Radioligand Therapy Market Size by Region (2017-2022)

6.2 APAC Radioligand Therapy Market Size by Used Radionuclides (2017-2022)

6.3 APAC Radioligand Therapy Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Radioligand Therapy by Country (2017-2022)

7.2 Europe Radioligand Therapy Market Size by Used Radionuclides (2017-2022)

7.3 Europe Radioligand Therapy Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Radioligand Therapy by Region (2017-2022)

8.2 Middle East & Africa Radioligand Therapy Market Size by Used Radionuclides (2017-2022)

8.3 Middle East & Africa Radioligand Therapy Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Radioligand Therapy Market Forecast

10.1 Global Radioligand Therapy Forecast by Regions (2023-2028)

10.1.1 Global Radioligand Therapy Forecast by Regions (2023-2028)

10.1.2 Americas Radioligand Therapy Forecast

10.1.3 APAC Radioligand Therapy Forecast

10.1.4 Europe Radioligand Therapy Forecast

10.1.5 Middle East & Africa Radioligand Therapy Forecast

10.2 Americas Radioligand Therapy Forecast by Country (2023-2028)

10.2.1 United States Radioligand Therapy Market Forecast

10.2.2 Canada Radioligand Therapy Market Forecast

10.2.3 Mexico Radioligand Therapy Market Forecast

10.2.4 Brazil Radioligand Therapy Market Forecast

10.3 APAC Radioligand Therapy Forecast by Region (2023-2028)

10.3.1 China Radioligand Therapy Market Forecast

10.3.2 Japan Radioligand Therapy Market Forecast

10.3.3 Korea Radioligand Therapy Market Forecast

10.3.4 Southeast Asia Radioligand Therapy Market Forecast

10.3.5 India Radioligand Therapy Market Forecast

10.3.6 Australia Radioligand Therapy Market Forecast

10.4 Europe Radioligand Therapy Forecast by Country (2023-2028)

10.4.1 Germany Radioligand Therapy Market Forecast

10.4.2 France Radioligand Therapy Market Forecast

10.4.3 UK Radioligand Therapy Market Forecast

10.4.4 Italy Radioligand Therapy Market Forecast

10.4.5 Russia Radioligand Therapy Market Forecast

10.5 Middle East & Africa Radioligand Therapy Forecast by Region (2023-2028)

10.5.1 Egypt Radioligand Therapy Market Forecast

10.5.2 South Africa Radioligand Therapy Market Forecast

10.5.3 Israel Radioligand Therapy Market Forecast

10.5.4 Turkey Radioligand Therapy Market Forecast

10.5.5 GCC Countries Radioligand Therapy Market Forecast

10.6 Global Radioligand Therapy Forecast by Used Radionuclides (2023-2028)

10.7 Global Radioligand Therapy Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Novartis

11.1.1 Novartis Company Information

11.1.2 Novartis Radioligand Therapy Product Offered

11.1.3 Novartis Radioligand Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Novartis Main Business Overview

11.1.5 Novartis Latest Developments

11.2 Advanced Accelerator Applications

11.2.1 Advanced Accelerator Applications Company Information

11.2.2 Advanced Accelerator Applications Radioligand Therapy Product Offered

11.2.3 Advanced Accelerator Applications Radioligand Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Advanced Accelerator Applications Main Business Overview

11.2.5 Advanced Accelerator Applications Latest Developments

11.3 Mercy Radiology

11.3.1 Mercy Radiology Company Information

11.3.2 Mercy Radiology Radioligand Therapy Product Offered

11.3.3 Mercy Radiology Radioligand Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Mercy Radiology Main Business Overview

11.3.5 Mercy Radiology Latest Developments

11.4 POINT Biopharma Global Inc

11.4.1 POINT Biopharma Global Inc Company Information

11.4.2 POINT Biopharma Global Inc Radioligand Therapy Product Offered

11.4.3 POINT Biopharma Global Inc Radioligand Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 POINT Biopharma Global Inc Main Business Overview

11.4.5 POINT Biopharma Global Inc Latest Developments

11.5 Fusion Pharma

11.5.1 Fusion Pharma Company Information

11.5.2 Fusion Pharma Radioligand Therapy Product Offered

11.5.3 Fusion Pharma Radioligand Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Fusion Pharma Main Business Overview

11.5.5 Fusion Pharma Latest Developments

11.6 Telix Pharmaceuticals Ltd

11.6.1 Telix Pharmaceuticals Ltd Company Information

11.6.2 Telix Pharmaceuticals Ltd Radioligand Therapy Product Offered

11.6.3 Telix Pharmaceuticals Ltd Radioligand Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Telix Pharmaceuticals Ltd Main Business Overview

11.6.5 Telix Pharmaceuticals Ltd Latest Developments

11.7 Lantheus Holdings, Inc

11.7.1 Lantheus Holdings, Inc Company Information

11.7.2 Lantheus Holdings, Inc Radioligand Therapy Product Offered

11.7.3 Lantheus Holdings, Inc Radioligand Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Lantheus Holdings, Inc Main Business Overview

11.7.5 Lantheus Holdings, Inc Latest Developments

11.8 Bayer AG

11.8.1 Bayer AG Company Information

11.8.2 Bayer AG Radioligand Therapy Product Offered

11.8.3 Bayer AG Radioligand Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Bayer AG Main Business Overview

11.8.5 Bayer AG Latest Developments

11.9 Curium Pharma

11.9.1 Curium Pharma Company Information

11.9.2 Curium Pharma Radioligand Therapy Product Offered

11.9.3 Curium Pharma Radioligand Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Curium Pharma Main Business Overview

11.9.5 Curium Pharma Latest Developments

11.10 Precirix

11.10.1 Precirix Company Information

11.10.2 Precirix Radioligand Therapy Product Offered

11.10.3 Precirix Radioligand Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Precirix Main Business Overview

11.10.5 Precirix Latest Developments

12 Research Findings and Conclusion

Table 1. Radioligand Therapy Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Actinium 225 (Ac-225)

Table 3. Major Players of Lutetium 177 (Lu-177)

Table 4. Major Players of Gallium 68 (Ga-68)

Table 5. Major Players of Fluorine 18 (F-18)

Table 6. Major Players of Other Radionuclides

Table 7. Radioligand Therapy Market Size CAGR by Used Radionuclides (2017 VS 2022 VS 2028) & ($ Millions)

Table 8. Global Radioligand Therapy Market Size by Used Radionuclides (2017-2022) & ($ Millions)

Table 9. Global Radioligand Therapy Market Size Market Share by Used Radionuclides (2017-2022)

Table 10. Radioligand Therapy Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 11. Global Radioligand Therapy Market Size by Application (2017-2022) & ($ Millions)

Table 12. Global Radioligand Therapy Market Size Market Share by Application (2017-2022)

Table 13. Global Radioligand Therapy Revenue by Players (2020-2022) & ($ Millions)

Table 14. Global Radioligand Therapy Revenue Market Share by Player (2020-2022)

Table 15. Radioligand Therapy Key Players Head office and Products Offered

Table 16. Radioligand Therapy Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 17. New Products and Potential Entrants

Table 18. Mergers & Acquisitions, Expansion

Table 19. Global Radioligand Therapy Market Size by Regions 2017-2022 & ($ Millions)

Table 20. Global Radioligand Therapy Market Size Market Share by Regions (2017-2022)

Table 21. Americas Radioligand Therapy Market Size by Country (2017-2022) & ($ Millions)

Table 22. Americas Radioligand Therapy Market Size Market Share by Country (2017-2022)

Table 23. Americas Radioligand Therapy Market Size by Used Radionuclides (2017-2022) & ($ Millions)

Table 24. Americas Radioligand Therapy Market Size Market Share by Used Radionuclides (2017-2022)

Table 25. Americas Radioligand Therapy Market Size by Application (2017-2022) & ($ Millions)

Table 26. Americas Radioligand Therapy Market Size Market Share by Application (2017-2022)

Table 27. APAC Radioligand Therapy Market Size by Region (2017-2022) & ($ Millions)

Table 28. APAC Radioligand Therapy Market Size Market Share by Region (2017-2022)

Table 29. APAC Radioligand Therapy Market Size by Used Radionuclides (2017-2022) & ($ Millions)

Table 30. APAC Radioligand Therapy Market Size Market Share by Used Radionuclides (2017-2022)

Table 31. APAC Radioligand Therapy Market Size by Application (2017-2022) & ($ Millions)

Table 32. APAC Radioligand Therapy Market Size Market Share by Application (2017-2022)

Table 33. Europe Radioligand Therapy Market Size by Country (2017-2022) & ($ Millions)

Table 34. Europe Radioligand Therapy Market Size Market Share by Country (2017-2022)

Table 35. Europe Radioligand Therapy Market Size by Used Radionuclides (2017-2022) & ($ Millions)

Table 36. Europe Radioligand Therapy Market Size Market Share by Used Radionuclides (2017-2022)

Table 37. Europe Radioligand Therapy Market Size by Application (2017-2022) & ($ Millions)

Table 38. Europe Radioligand Therapy Market Size Market Share by Application (2017-2022)

Table 39. Middle East & Africa Radioligand Therapy Market Size by Region (2017-2022) & ($ Millions)

Table 40. Middle East & Africa Radioligand Therapy Market Size Market Share by Region (2017-2022)

Table 41. Middle East & Africa Radioligand Therapy Market Size by Used Radionuclides (2017-2022) & ($ Millions)

Table 42. Middle East & Africa Radioligand Therapy Market Size Market Share by Used Radionuclides (2017-2022)

Table 43. Middle East & Africa Radioligand Therapy Market Size by Application (2017-2022) & ($ Millions)

Table 44. Middle East & Africa Radioligand Therapy Market Size Market Share by Application (2017-2022)

Table 45. Key Market Drivers & Growth Opportunities of Radioligand Therapy

Table 46. Key Market Challenges & Risks of Radioligand Therapy

Table 47. Key Industry Trends of Radioligand Therapy

Table 48. Global Radioligand Therapy Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 49. Global Radioligand Therapy Market Size Market Share Forecast by Regions (2023-2028)

Table 50. Global Radioligand Therapy Market Size Forecast by Used Radionuclides (2023-2028) & ($ Millions)

Table 51. Global Radioligand Therapy Market Size Market Share Forecast by Used Radionuclides (2023-2028)

Table 52. Global Radioligand Therapy Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 53. Global Radioligand Therapy Market Size Market Share Forecast by Application (2023-2028)

Table 54. Novartis Details, Company Type, Radioligand Therapy Area Served and Its Competitors

Table 55. Novartis Radioligand Therapy Product Offered

Table 56. Novartis Radioligand Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 57. Novartis Main Business

Table 58. Novartis Latest Developments

Table 59. Advanced Accelerator Applications Details, Company Type, Radioligand Therapy Area Served and Its Competitors

Table 60. Advanced Accelerator Applications Radioligand Therapy Product Offered

Table 61. Advanced Accelerator Applications Main Business

Table 62. Advanced Accelerator Applications Radioligand Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 63. Advanced Accelerator Applications Latest Developments

Table 64. Mercy Radiology Details, Company Type, Radioligand Therapy Area Served and Its Competitors

Table 65. Mercy Radiology Radioligand Therapy Product Offered

Table 66. Mercy Radiology Main Business

Table 67. Mercy Radiology Radioligand Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 68. Mercy Radiology Latest Developments

Table 69. POINT Biopharma Global Inc Details, Company Type, Radioligand Therapy Area Served and Its Competitors

Table 70. POINT Biopharma Global Inc Radioligand Therapy Product Offered

Table 71. POINT Biopharma Global Inc Main Business

Table 72. POINT Biopharma Global Inc Radioligand Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 73. POINT Biopharma Global Inc Latest Developments

Table 74. Fusion Pharma Details, Company Type, Radioligand Therapy Area Served and Its Competitors

Table 75. Fusion Pharma Radioligand Therapy Product Offered

Table 76. Fusion Pharma Main Business

Table 77. Fusion Pharma Radioligand Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 78. Fusion Pharma Latest Developments

Table 79. Telix Pharmaceuticals Ltd Details, Company Type, Radioligand Therapy Area Served and Its Competitors

Table 80. Telix Pharmaceuticals Ltd Radioligand Therapy Product Offered

Table 81. Telix Pharmaceuticals Ltd Main Business

Table 82. Telix Pharmaceuticals Ltd Radioligand Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 83. Telix Pharmaceuticals Ltd Latest Developments

Table 84. Lantheus Holdings, Inc Details, Company Type, Radioligand Therapy Area Served and Its Competitors

Table 85. Lantheus Holdings, Inc Radioligand Therapy Product Offered

Table 86. Lantheus Holdings, Inc Main Business

Table 87. Lantheus Holdings, Inc Radioligand Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 88. Lantheus Holdings, Inc Latest Developments

Table 89. Bayer AG Details, Company Type, Radioligand Therapy Area Served and Its Competitors

Table 90. Bayer AG Radioligand Therapy Product Offered

Table 91. Bayer AG Main Business

Table 92. Bayer AG Radioligand Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 93. Bayer AG Latest Developments

Table 94. Curium Pharma Details, Company Type, Radioligand Therapy Area Served and Its Competitors

Table 95. Curium Pharma Radioligand Therapy Product Offered

Table 96. Curium Pharma Main Business

Table 97. Curium Pharma Radioligand Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 98. Curium Pharma Latest Developments

Table 99. Precirix Details, Company Type, Radioligand Therapy Area Served and Its Competitors

Table 100. Precirix Radioligand Therapy Product Offered

Table 101. Precirix Main Business

Table 102. Precirix Radioligand Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 103. Precirix Latest Developments

List of Figures

Figure 1. Radioligand Therapy Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Radioligand Therapy Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Radioligand Therapy Market Size Market Share by Used Radionuclides in 2021

Figure 7. Radioligand Therapy in Neuroendocrine Neoplasms

Figure 8. Global Radioligand Therapy Market: Neuroendocrine Neoplasms (2017-2022) & ($ Millions)

Figure 9. Radioligand Therapy in Prostate Cancer

Figure 10. Global Radioligand Therapy Market: Prostate Cancer (2017-2022) & ($ Millions)

Figure 11. Global Radioligand Therapy Market Size Market Share by Application in 2021

Figure 12. Global Radioligand Therapy Revenue Market Share by Player in 2021

Figure 13. Global Radioligand Therapy Market Size Market Share by Regions (2017-2022)

Figure 14. Americas Radioligand Therapy Market Size 2017-2022 ($ Millions)

Figure 15. APAC Radioligand Therapy Market Size 2017-2022 ($ Millions)

Figure 16. Europe Radioligand Therapy Market Size 2017-2022 ($ Millions)

Figure 17. Middle East & Africa Radioligand Therapy Market Size 2017-2022 ($ Millions)

Figure 18. Americas Radioligand Therapy Value Market Share by Country in 2021

Figure 19. Americas Radioligand Therapy Consumption Market Share by Used Radionuclides in 2021

Figure 20. Americas Radioligand Therapy Market Size Market Share by Application in 2021

Figure 21. United States Radioligand Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 22. Canada Radioligand Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 23. Mexico Radioligand Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 24. Brazil Radioligand Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 25. APAC Radioligand Therapy Market Size Market Share by Region in 2021

Figure 26. APAC Radioligand Therapy Market Size Market Share by Application in 2021

Figure 27. China Radioligand Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 28. Japan Radioligand Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 29. Korea Radioligand Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 30. Southeast Asia Radioligand Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 31. India Radioligand Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 32. Australia Radioligand Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 33. Europe Radioligand Therapy Market Size Market Share by Country in 2021

Figure 34. Europe Radioligand Therapy Market Size Market Share by Used Radionuclides in 2021

Figure 35. Europe Radioligand Therapy Market Size Market Share by Application in 2021

Figure 36. Germany Radioligand Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 37. France Radioligand Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 38. UK Radioligand Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 39. Italy Radioligand Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 40. Russia Radioligand Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 41. Middle East & Africa Radioligand Therapy Market Size Market Share by Region in 2021

Figure 42. Middle East & Africa Radioligand Therapy Market Size Market Share by Used Radionuclides in 2021

Figure 43. Middle East & Africa Radioligand Therapy Market Size Market Share by Application in 2021

Figure 44. Egypt Radioligand Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 45. South Africa Radioligand Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 46. Israel Radioligand Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 47. Turkey Radioligand Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 48. GCC Country Radioligand Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 49. Americas Radioligand Therapy Market Size 2023-2028 ($ Millions)

Figure 50. APAC Radioligand Therapy Market Size 2023-2028 ($ Millions)

Figure 51. Europe Radioligand Therapy Market Size 2023-2028 ($ Millions)

Figure 52. Middle East & Africa Radioligand Therapy Market Size 2023-2028 ($ Millions)

Figure 53. United States Radioligand Therapy Market Size 2023-2028 ($ Millions)

Figure 54. Canada Radioligand Therapy Market Size 2023-2028 ($ Millions)

Figure 55. Mexico Radioligand Therapy Market Size 2023-2028 ($ Millions)

Figure 56. Brazil Radioligand Therapy Market Size 2023-2028 ($ Millions)

Figure 57. China Radioligand Therapy Market Size 2023-2028 ($ Millions)

Figure 58. Japan Radioligand Therapy Market Size 2023-2028 ($ Millions)

Figure 59. Korea Radioligand Therapy Market Size 2023-2028 ($ Millions)

Figure 60. Southeast Asia Radioligand Therapy Market Size 2023-2028 ($ Millions)

Figure 61. India Radioligand Therapy Market Size 2023-2028 ($ Millions)

Figure 62. Australia Radioligand Therapy Market Size 2023-2028 ($ Millions)

Figure 63. Germany Radioligand Therapy Market Size 2023-2028 ($ Millions)

Figure 64. France Radioligand Therapy Market Size 2023-2028 ($ Millions)

Figure 65. UK Radioligand Therapy Market Size 2023-2028 ($ Millions)

Figure 66. Italy Radioligand Therapy Market Size 2023-2028 ($ Millions)

Figure 67. Russia Radioligand Therapy Market Size 2023-2028 ($ Millions)

Figure 68. Spain Radioligand Therapy Market Size 2023-2028 ($ Millions)

Figure 69. Egypt Radioligand Therapy Market Size 2023-2028 ($ Millions)

Figure 70. South Africa Radioligand Therapy Market Size 2023-2028 ($ Millions)

Figure 71. Israel Radioligand Therapy Market Size 2023-2028 ($ Millions)

Figure 72. Turkey Radioligand Therapy Market Size 2023-2028 ($ Millions)

Figure 73. GCC Countries Radioligand Therapy Market Size 2023-2028 ($ Millions)